Name | Number of supported studies | Average coverage | |
---|---|---|---|
brush cell | 3 studies | 71% ± 16% |
Insufficient scRNA-seq data for expression of TRPM5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 254.11 | 328 / 328 | 47% | 3.90 | 83 / 178 |
thymus | 100% | 326.61 | 652 / 653 | 13% | 0.92 | 80 / 605 |
intestine | 61% | 281.95 | 593 / 966 | 45% | 1.43 | 236 / 527 |
stomach | 70% | 39.95 | 253 / 359 | 34% | 1.03 | 98 / 286 |
kidney | 100% | 139.06 | 89 / 89 | 1% | 0.07 | 5 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.61 | 1 / 1 |
adrenal gland | 98% | 148.31 | 254 / 258 | 0% | 0.01 | 1 / 230 |
prostate | 54% | 30.50 | 132 / 245 | 2% | 0.08 | 10 / 502 |
spleen | 54% | 16.33 | 130 / 241 | 0% | 0 | 0 / 0 |
bladder | 33% | 20.24 | 7 / 21 | 20% | 0.75 | 103 / 504 |
uterus | 36% | 9.78 | 61 / 170 | 11% | 0.53 | 50 / 459 |
ovary | 6% | 1.77 | 11 / 180 | 31% | 1.19 | 134 / 430 |
lung | 18% | 4.69 | 105 / 578 | 10% | 0.55 | 115 / 1155 |
esophagus | 1% | 0.50 | 21 / 1445 | 17% | 0.69 | 31 / 183 |
skin | 12% | 4.77 | 225 / 1809 | 1% | 0.01 | 3 / 472 |
brain | 7% | 1.60 | 176 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 6% | 1.57 | 59 / 929 | 0% | 0 | 0 / 0 |
breast | 3% | 1.01 | 16 / 459 | 2% | 0.17 | 19 / 1118 |
liver | 1% | 0.25 | 3 / 226 | 1% | 0.04 | 5 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.08 | 1 / 45 |
adipose | 2% | 0.51 | 25 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.32 | 16 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 0.15 | 7 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.19 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0034702 | Cellular component | monoatomic ion channel complex |
GO_0043025 | Cellular component | neuronal cell body |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030425 | Cellular component | dendrite |
GO_0099604 | Molecular function | ligand-gated calcium channel activity |
GO_0005267 | Molecular function | potassium channel activity |
GO_0005272 | Molecular function | sodium channel activity |
GO_0005216 | Molecular function | monoatomic ion channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0005227 | Molecular function | calcium-activated cation channel activity |
Gene name | TRPM5 |
Protein name | Transient receptor potential cation channel subfamily M member 5 TRPM5 protein Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein) |
Synonyms | MTR1 LTRPC5 |
Description | FUNCTION: Voltage-modulated Ca(2+)-activated, monovalent cation channel (VCAM) that mediates a transient membrane depolarization and plays a central role in taste transduction. Monovalent-specific, non-selective cation channel that mediates the transport of Na(+), K(+) and Cs(+) ions equally well. Activated directly by increases in intracellular Ca(2+), but is impermeable to it. Gating is voltage-dependent and displays rapid activation and deactivation kinetics upon channel stimulation even during sustained elevations in Ca(2+). Also activated by a fast intracellular Ca(2+) increase in response to inositol 1,4,5-triphosphate-producing receptor agonists. The channel is blocked by extracellular acidification. External acidification has 2 effects, a fast reversible block of the current and a slower irreversible enhancement of current inactivation. Is a highly temperature-sensitive, heat activated channel showing a steep increase of inward currents at temperatures between 15 and 35 degrees Celsius. Heat activation is due to a shift of the voltage-dependent activation curve to negative potentials. Activated by arachidonic acid in vitro. May be involved in perception of bitter, sweet and umami tastes. May also be involved in sensing semiochemicals. . |
Accessions | ENST00000696290.1 [Q9NZQ8-1] E9PRW0 ENST00000533060.5 A0A0C4DGF4 Q9NZQ8 B7ZKS6 B7ZKS5 E9PQF7 ENST00000528453.1 ENST00000533881.5 |